| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Executive Recruiting |
|
Digg It - Executive Recruiting
Performing the function of recruitment i.e., increasing the selection ratio, is not as easy as it seems to According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product be. This is because of the hurdles created by the internal factors and external factors that influence an o ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rganization. The first activity of executive recruiting i.e., searching for prospective employees is affect lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ed by many factors like organizational policy regarding filling up of certain percentage of vacancies by in here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ernal candidates, local candidates, influence of trade unions, government regulations regarding reservation d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s of certain number of vacancies to candidates based on community/region/sex. As such, the management is n ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ot free to find out or develop the source of desirable candidates and alternatively it has to divert its en easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ergies for developing the sources within the limits of those factors. The other activity of executive recru nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically tment is affected by the internal factors such as working conditions, promotional opportunities, salary lev and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ els, type and extent of benefits, image of the organization and ability and skill of the management to stim ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ulate the candidates. It is also affected by external factors like personnel policies and practices of var ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ious organizations including working conditions, salary, benefits, promotional opportunities, and career op dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ortunities in other organizations. However, formulating sound policies can minimize the degree of complexit cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin y of recruitment function. The recruitment policy of any organization is derived from the personnel policy tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen of the same organization. In other words, the former is a part of the latter. However, recruitment policy t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel by itself should take into consideration personnel policies of other organizations regarding merit, interna ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust sources. Recruitment policy should commit itself to the organization personnel policy like enriching the o y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rganization human resources or serving the community by absorbing the disadvantaged people of the society. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de Motivating the employees through internal promotions and improving the employee loyalty to the organization elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip by absorbing the retrenched or laid off employees or temporary employees or dependents of former employees tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Logo Designers Would Give Michael Jordan a Run for His Money. Take Control of Your Design Experience Boomerang Customers- What You Might NOT Think Brings Them Back!
|